Impax Labs Inc (IPXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPXL | SUPN | TSHA | ||
| Company | Impax Labs Inc | Supernus Pharm | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.20 | 30.53 | 2.49 | ||
| High | 18.95 | 30.66 | 2.64 | ||
| Low | 17.40 | 29.79 | 2.41 | ||
| Last | 18.30 | 30.27 | 2.58 | ||
| Change | unch | +0.19 | +0.16 | ||
| % Change | unch | +0.63% | +6.61% | ||
| Volume | 3,041,000 | 319,300 | 1,491,500 | ||
| 20-Day Average Volume | 870,975 | 356,050 | 1,850,510 | ||
| Previous Close | 18.30 | 30.08 | 2.42 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.17 | 30.39 | 2.59 | ||
| 20-Day Raw Stochastic | 26.47% | 33.00% | 34.66% | ||
| 20-Day Relative Strength | 43.41% | 47.41% | 51.09% | ||
| Weighted Alpha | +16.20 | -11.30 | +18.89 | ||
| Today's Opinion | N/A | 40% Buy | 40% Buy | ||
| Previous Opinion | N/A | 40% Buy | 40% Buy | ||
| Last Month's Opinion | N/A | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.68% since 04/27/18 | +3.28% since 04/25/24 | +12.17% since 04/25/24 | ||
| Low | 17.40 on 05/04/18 | 29.17 on 04/26/24 | 2.30 on 04/26/24 | ||
| High | 20.80 on 05/02/18 | 31.27 on 04/29/24 | 2.64 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | -7.34% since 04/04/18 | -8.74% since 04/02/24 | -4.80% since 04/02/24 | ||
| Low | 17.40 on 05/04/18 | 28.63 on 04/18/24 | 2.14 on 04/19/24 | ||
| High | 20.80 on 05/02/18 | 34.49 on 04/04/24 | 3.40 on 04/10/24 | ||
| 3-Month | |||||
| %Chg | -5.67% since 02/02/18 | +9.40% since 02/02/24 | +70.86% since 02/02/24 | ||
| Low | 17.40 on 05/04/18 | 26.27 on 02/28/24 | 1.41 on 02/14/24 | ||
| High | 21.55 on 02/26/18 | 35.44 on 03/21/24 | 3.55 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | -1.35% since 11/03/17 | +25.76% since 11/02/23 | +7.50% since 11/02/23 | ||
| Low | 15.60 on 12/07/17 | 23.05 on 11/07/23 | 1.27 on 11/14/23 | ||
| High | 21.75 on 01/26/18 | 35.44 on 03/21/24 | 3.55 on 03/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,351,821 | 1,653,618 | 452,584 | ||
| Shares Outstanding, K | 73,870 | 54,974 | 187,018 | ||
| Annual Sales | 775,790,000 | 607,520,000 | 15,450,000 | ||
| Annual Net Income | -469,290,000 | 1,320,000 | -111,570,000 | ||
| Last Quarter Sales | 182,910,000 | 164,310,000 | 3,600,000 | ||
| Last Quarter Net Income | -301,070,000 | 1,170,000 | 47,740,000 | ||
| 60-Month Beta | 1.15 | 1.01 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.11 on 03/01/18 | 0.02 on 02/27/24 | 0.35 on 03/19/24 | ||
| Latest Earnings Date | 05/09/18 | 05/08/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 29.05 | 0.00 | 0.00 | ||